InsiderClue
Insiders · Profile

Pontifax Management 4 G.P. (2015) Ltd.

10% owner at Keros Therapeutics · 10% owner at LB PHARMACEUTICALS · 10% owner at Eloxx Pharmaceuticals. Filing since 21 Mar 2018. CIK 0001726334

KROS Keros Therapeutics, Inc. 10% owner · 3 trades LBRX LB PHARMACEUTICALS INC 10% owner · 1 trade ELOX Eloxx Pharmaceuticals, Inc. 10% owner · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
KROS Keros Therapeutics, Inc.
15 Oct 2025
10% owner
Sold at will
4,787,331
$84.98M
100%
LBRX LB PHARMACEUTICALS INC
12 Sep 2025
10% owner
Bought
1,000,000
$15.00M
243%
ELOX Eloxx Pharmaceuticals, Inc.
13 May 2021
10% owner
Bought
5,925,925
$8.00M
opened
KROS Keros Therapeutics, Inc.
17 Nov 2020
10% owner
Bought
60,000
$3.00M
2.7%
KROS Keros Therapeutics, Inc.
13 Apr 2020
10% owner
Bought
437,499
$7.00M
24.0%
ELOX Eloxx Pharmaceuticals, Inc.
24 Jun 2019
10% owner
Bought
200,000
$1.80M
23.5%
ELOX Eloxx Pharmaceuticals, Inc.
30 Apr 2018
10% owner
Bought
350,000
$3.41M
57.1%
ELOX Eloxx Pharmaceuticals, Inc.
22 Mar 2018
10% owner
Bought
6,000
$48.00K
0.8%
ELOX Eloxx Pharmaceuticals, Inc.
21 Mar 2018
10% owner
Bought
6,600
$49.83K
0.8%
9 decisions on file.